These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 25087979)

  • 1. The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation.
    Tremblay AM; Missiaglia E; Galli GG; Hettmer S; Urcia R; Carrara M; Judson RN; Thway K; Nadal G; Selfe JL; Murray G; Calogero RA; De Bari C; Zammit PS; Delorenzi M; Wagers AJ; Shipley J; Wackerhage H; Camargo FD
    Cancer Cell; 2014 Aug; 26(2):273-87. PubMed ID: 25087979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAPping about differentiation therapy in muscle cancer.
    Svalina MN; Keller C
    Cancer Cell; 2014 Aug; 26(2):154-5. PubMed ID: 25117705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the relationship between the KRAS G12V oncogene and the Hippo effector YAP1 in embryonal rhabdomyosarcoma.
    Mohamed AD; Shah N; Hettmer S; Vargesson N; Wackerhage H
    Sci Rep; 2018 Oct; 8(1):15674. PubMed ID: 30353028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma.
    Mohamed A; Sun C; De Mello V; Selfe J; Missiaglia E; Shipley J; Murray GI; Zammit PS; Wackerhage H
    J Pathol; 2016 Sep; 240(1):3-14. PubMed ID: 27184927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YAP1 enhances NF-κB-dependent and independent effects on clock-mediated unfolded protein responses and autophagy in sarcoma.
    Rivera-Reyes A; Ye S; E Marino G; Egolf S; E Ciotti G; Chor S; Liu Y; Posimo JM; Park PMC; Pak K; Babichev Y; Sostre-Colón J; Tameire F; Leli NM; Koumenis C; C Brady D; Mancuso A; Weber K; Gladdy R; Qi J; Eisinger-Mathason TSK
    Cell Death Dis; 2018 Oct; 9(11):1108. PubMed ID: 30382078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG.
    Liu Z; Zhang X; Lei H; Lam N; Carter S; Yockey O; Xu M; Mendoza A; Hernandez ER; Wei JS; Khan J; Yohe ME; Shern JF; Thiele CJ
    Nat Commun; 2020 Feb; 11(1):911. PubMed ID: 32060262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP1-TEAD1 signaling controls angiogenesis and mitochondrial biogenesis through PGC1α.
    Mammoto A; Muyleart M; Kadlec A; Gutterman D; Mammoto T
    Microvasc Res; 2018 Sep; 119():73-83. PubMed ID: 29680477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis.
    Belyea BC; Naini S; Bentley RC; Linardic CM
    Clin Cancer Res; 2011 Dec; 17(23):7324-36. PubMed ID: 21948088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.
    Ota M; Sasaki H
    Development; 2008 Dec; 135(24):4059-69. PubMed ID: 19004856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood Rhabdomyosarcoma.
    Slemmons KK; Yeung C; Baumgart JT; Juarez JOM; McCalla A; Helman LJ
    Cancer Res; 2020 Jul; 80(14):3046-3056. PubMed ID: 32354737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma.
    Slemmons KK; Crose LES; Riedel S; Sushnitha M; Belyea B; Linardic CM
    Mol Cancer Res; 2017 Dec; 15(12):1777-1791. PubMed ID: 28923841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAGE signaling deficiency in rhabdomyosarcoma cells causes upregulation of PAX7 and uncontrolled proliferation.
    Riuzzi F; Sorci G; Sagheddu R; Sidoni A; Alaggio R; Ninfo V; Donato R
    J Cell Sci; 2014 Apr; 127(Pt 8):1699-711. PubMed ID: 24554430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines".
    Sanna L; Piredda R; Marchesi I; Bordoni V; Forcales SV; Calvisi DF; Bagella L
    Chem Biol Interact; 2019 Oct; 312():108813. PubMed ID: 31494105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YAP1-TEAD1-Glut1 axis dictates the oncogenic phenotypes of breast cancer cells by modulating glycolysis.
    Lin C; Xu X
    Biomed Pharmacother; 2017 Nov; 95():789-794. PubMed ID: 28892790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP1 and PRDM14 converge to promote cell survival and tumorigenesis.
    Kim M; Ly SH; Xie Y; Duronio GN; Ford-Roshon D; Hwang JH; Sulahian R; Rennhack JP; So J; Gjoerup O; Talamas JA; Grandclaudon M; Long HW; Doench JG; Sethi NS; Giannakis M; Hahn WC
    Dev Cell; 2022 Jan; 57(2):212-227.e8. PubMed ID: 34990589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired Wnt signaling in embryonal rhabdomyosarcoma cells from p53/c-fos double mutant mice.
    Singh S; Vinson C; Gurley CM; Nolen GT; Beggs ML; Nagarajan R; Wagner EF; Parham DM; Peterson CA
    Am J Pathol; 2010 Oct; 177(4):2055-66. PubMed ID: 20829439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis.
    Ye S; Lawlor MA; Rivera-Reyes A; Egolf S; Chor S; Pak K; Ciotti GE; Lee AC; Marino GE; Shah J; Niedzwicki D; Weber K; Park PMC; Alam MZ; Grazioli A; Haldar M; Xu M; Perry JA; Qi J; Eisinger-Mathason TSK
    Cancer Res; 2018 May; 78(10):2705-2720. PubMed ID: 29490948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease.
    Simile MM; Latte G; Demartis MI; Brozzetti S; Calvisi DF; Porcu A; Feo CF; Seddaiu MA; Daino L; Berasain C; Tomasi ML; Avila MA; Feo F; Pascale RM
    Oncotarget; 2016 Aug; 7(31):49194-49216. PubMed ID: 27359056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers.
    Stein C; Bardet AF; Roma G; Bergling S; Clay I; Ruchti A; Agarinis C; Schmelzle T; Bouwmeester T; Schübeler D; Bauer A
    PLoS Genet; 2015 Aug; 11(8):e1005465. PubMed ID: 26295846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle.
    Figeac N; Mohamed AD; Sun C; Schönfelder M; Matallanas D; Garcia-Munoz A; Missiaglia E; Collie-Duguid E; De Mello V; Pobbati AV; Pruller J; Jaka O; Harridge SDR; Hong W; Shipley J; Vargesson N; Zammit PS; Wackerhage H
    J Cell Sci; 2019 Jul; 132(13):. PubMed ID: 31138678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.